Does your faith need strengthening? Are you confused and wondering if Jesus Christ is really "The Way, the Truth, and the Life?" "Fight for Your Faith" is a blog filled with interesting and thought provoking articles to help you find the answers you are seeking. Jesus said, "Seek and ye shall find." In Jeremiah we read, "Ye shall seek Me, and find Me, when ye shall seek for Me with all your heart." These articles and videos will help you in your search for the Truth.

Saturday, May 2, 2026

Thursday, April 23, 2026

Monday, February 2, 2026

Friday, May 26, 2023

Tuesday, March 28, 2023

Monday, December 12, 2022

Found Dead at Home After COVID-19 Vaccination

Autopsy series finds an array of fatal vaccine syndromes

0:001:38

The public is becoming increasingly disturbed with reports of death among the vaccinated. It is natural to ask “was the death caused by vaccination?” The most definitive way of answering that question is with autopsy.

Schwab et al reported on deaths after vaccination with detailed autopsies in Heidelberg, Germany.[i] Of 35 fatalities within 20 days of injection, 10 were ruled out as clearly not due to the vaccine (eg drug overdose). The remaining 25 (71%) had final diagnoses consistent with a vaccine injury syndrome including myocardial infarction, worsening heart failure, vascular aneurysm, pulmonary embolism, fatal stroke, and vaccine-induced thrombotic thrombocytopenia. Interestingly, 5 cases had acute myocarditis as the cause of death with the histopathology in the heart muscle showing patchy inflammation very similar to what was seen in the deltoid muscle were the mRNA vaccine was injected.

Epoch Times Photo

Schwab, C., Domke, L.M., Hartmann, L. et al. Autopsy-based histopathological characterization of 
myocarditis after anti-SARS-CoV-2-vaccination. Clin Res Cardiol (2022). 
https://doi.org/10.1007/s00392-022-02129-5

So the report has told us:

1) 71% of deaths that occur within 20 days of taking vaccine appear to be due to conditions well known to occur with COVID-19 vaccination,

2) inflammation in the heart was coincident with the same pattern of inflammation in the arm. Thus we can conclude death within a few days of vaccination is most likely due to the genetic product and that inflammation in the arm may be a surrogate for a similar process in the heart.

The very high yield of post-vaccination autopsy should spur families and physicians to push for post-mortem exams so we can learn more on how this medical procedure is leading to such a large loss of human life.

Reposted from the author’s Substack


[i] Schwab, C., Domke, L.M., Hartmann, L. et al. Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination. Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-02129-5

Views expressed in this article are the opinions of the author and do not necessarily reflect the views of The Epoch Times.https://www.theepochtimes.com/found-dead-at-home-after-covid-19-vaccination-autopsies-finds-an-array-of-fatal-vaccine-injuries_4903958.html?utm_source

Sunday, December 11, 2022

COVID-19 Vaccination Likely Caused Fatal Heart Inflammation

 Autopsies Show COVID-19 Vaccination Likely Caused Fatal Heart Inflammation: Study

0:008:54

A serious side effect linked to COVID-19 vaccines can lead to death, according to a new study.

Post-vaccination myocarditis, a form of heart inflammation, was identified in a subset of people who died “unexpectedly” at home within 20 days of receiving a COVID-19 vaccine. Researchers analyzed autopsies that had been performed on the people and conducted additional research, including studying tissue samples.

Researchers started with a group of 35, but excluded 10 from further analysis because other causes of death were identified. Of the remaining 25, researchers identified evidence of myocarditis in five.

All of the five people received a Moderna or Pfizer vaccine within seven days of their death, with a mean of 2.5 days. The median age was 58 years. None of the people had COVID-19 infection prior to being vaccinated and nasal swabs returned negative.

Autopsy findings combined with the lack of evidence of other causes of death and how the vaccination happened shortly before the deaths enabled researchers to say that for three of the cases, vaccination was the “likely cause” of the myocarditis and that the cardiac condition “was the cause of sudden death.”

In one of the other cases, myocarditis was believed to be the cause of death but researchers detected a herpes virus, an alternative explanation for the incidence of heart inflammation. The remaining case did not include an alternative explanation for the myocarditis but the researchers said the impact of the inflammation was “discrete and mainly observed in the pericardial fat.” They classified the two cases as possibly caused by vaccination.

“In general, a causal link between myocarditis and anti-SARS-CoV-2 vaccination is supported by several considerations,” the researchers said, including the “close temporal relation to vaccination”; the “absence of any other significant pre-existing heart disease”; and the negative testing for any “myocarditis-causing infectious agents.”

Limitations included the small cohort size.

The study (pdf) was published by Clinical Research in Cardiology on Nov. 27. The researchers all work for Heidelberg University Hospital. They were funded by German authorities.

Moderna and Pfizer did not respond to requests for comment.

The meticulous ruling out of possible causes apart from vaccination signals that the cases are “the tip of the iceberg,” Dr. Andrew Bostom, a heart expert based in Rhode Island, told The Epoch Times.

“If there’s a seemingly healthy person that dies suddenly in their sleep, essentially, these are typically the cases that are autopsied, and clearly the most common finding is some form of atherosclerotic coronary heart disease. But they basically ruled that out in these cases. And then they came up with the most plausible proximate cause being vaccination,” he said. “And so it suggests that the phenomenon could actually be broader than it’s been suspected to be.”

Myocarditis

Myocarditis is a serious heart condition that can manifest as chest pain and typically leads the sufferer to seek hospital care.

Doctors usually advise against all or most physical activity for a period of time.

Causes include bacteria, viruses, and fever.

Acute myocarditis resolves in about half of cases in the first two to four weeks, researchers have found, but another quarter feature longer-term problems and many of the rest lead to death or heart transplantation.

The incidence of myocarditis among COVID-19 vaccine recipients was higher than expected, researchers in the United States, Israel, and other countries have found. The highest rates have been detected in young people, particularly young males.

Estimates of the typical myocarditis incidence rates are 0.2 to 2.2 per million persons within seven days. Reports to the Vaccine Adverse Event Reporting System show higher rates for males aged 5 to 49 and females aged 12 to 29. The highest rate was 75.9 per million second doses administered. Reports to the system don’t prove causality but the system suffers from severe underreporting, according to studies, indicating the rates are even higher.

The U.S. Centers for Disease Control and Prevention (CDC) continues to recommend vaccination for virtually all people aged 6 months and older, asserting that the benefits of the vaccines outweigh the risks. Some experts disagree, saying side effects like myocarditis tilt the calculus to the risks being higher in some age groups.

Government officials have repeatedly said that most of the myocarditis cases resolve within weeks, but CDC researchers found in September that many youths who experienced post-vaccination myocarditis still had abnormal MRI results months later.

The incidence has been much lower among older people, according to U.S. authorities, which have refused to make public the autopsy results of people who die after vaccination, and various studies.

The new study “suggests we’ve been missing some severe myo[carditis] cases in our studies,” Dr. Tracy Høeg, an epidemiologist who advises the Florida Department of Health, said on Twitter.

Causality

Several vaccines have been linked to myocarditis and a related condition, pericarditis. They are made by Moderna and Pfizer and are the two most widely administered in the United States and Germany.

Both vaccines utilize messenger RNA (mRNA) technology.

Causality means that a vaccine causes a condition.

Top CDC researchers have said (pdf) the current evidence shows a causal link between the mRNA shots and heart inflammation. Other researchers have also reached that conclusion.

The U.S. Food and Drug Administration warns potential vaccine recipients that “postmarketing data demonstrate increased risks of myocarditis and pericarditis, particularly within 7 days following the second dose.”

Bostom said the evidence he’s reviewed shows a causal link.

“It’s as certain as most associations that we say are confirmed in medicine,” he said.

Some studies have identified COVID-19  as another cause of myocarditis and pericarditis, but others have indicated it might not be associated.

Other Autopsy Findings

Before the German study, other researchers around the world had reported findings from autopsies of people who died suddenly after vaccination.

In 2021, U.S. researchers reported two adults developed myocarditis within two weeks of COVID-19 vaccination, and they were unable to find causes other than vaccination.

In 2021, South Korea researchers reported that after examining the death of a 22-year-old man who died five days after receiving the Pfizer vaccine, they determined the primary cause was “myocarditis, causally-associated” with the vaccine.

In January, New Zealand researchers reported that the Pfizer vaccine was probably responsible for sudden myocarditis that led to the death of a 57-year-old woman, writing that “other causes have been discounted with reasonable certainty.”

In February, researchers in several U.S. states reported that two teenage boys who died shortly after receiving Pfizer’s vaccine experienced heart inflammation and that the inflammation was the primary cause of death.

In May, CDC researchers reported that a young boy died after experiencing post-vaccination heart inflammation, with myocarditis being pegged as the cause of death.

In September, a German researcher reported that a 55-year-old who died four months after receiving the Pfizer vaccine died of myocarditis and said “these findings indicate that myocarditis, as well as thrombo-embolic events following injection of spike-inducing gene-based vaccines, are causally associated with a[n] injurious immunological response to the encoded agent.”

And just recently, Japanese researchers reported on results from a 27-year-old man who died 28 days after admission following vaccination.

Zachary Stieber 
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news.

Cause Unknown: The Epidemic of Sudden Deaths in 2021 and 2022

STORY AT-A-GLANCE
In his new book, “Cause Unknown: The Epidemic of Sudden Deaths in 2021 and 2022,” former BlackRock fund manager Edward Dowd details data showing the COVID shots are a crime against humanity.

Insurance industry research in 2016 concluded that group life policyholders die at one-third the rate of the general U.S. population, so they're the healthiest among us. Group life policyholders are those employed with Fortune 500 companies, who tend to be younger and well-educated.
In 2020, the general U.S. population had higher excess mortality than group life holders, but in 2021, that flipped. Ages 25 through 64 of the group life policyholders suddenly experienced 40% excess mortality, compared to 32% in the general population. In short, a far healthier subset of the population suddenly died at a higher rate than the general population.
American disability statistics are equally revealing. In the five years before COVID, the monthly disability rate was between 29 million and 30 million. After the COVID jabs, the disability trend changed dramatically. As of September 2022, there were 33.2 million disabled Americans — an extra 3.2 million to 4.2 million — a three standard deviation rate of change since May 2021.
Since May 2021, the overall U.S. population has experienced an 11% increase in disabilities, while the employed — which is about 98 million out of a total population of about 320 million — experienced 26% increased rate of disability. So, something was introduced into the workforce that caused working age people to die.

In this video, I interview repeat guest Edward (Ed) Dowd, a former analyst and fund manager with BlackRock, the largest asset manager in the world. With more than $10 trillion in assets, BlackRock wields greater financial power than any country in the world with the exception of the U.S. and China.

Dowd has a knack for seeing trends, and was able to grow the assets he managed during his time at BlackRock from $2 billion to $14 billion. Ten years ago, he left BlackRock, moved to Maui and became an entrepreneur. More recently, he's come out as a whistleblower against the COVID shots and Big Pharma corruption.

In our last interview, we discussed the mathematical certainty of a financial collapse, and how COVID provided a convenient smoke screen to hide this reality.
Data Reveals Crimes Against Humanity

Dowd has now published a book, "Cause Unknown: The Epidemic of Sudden Deaths in 2021 and 2022," in which he details the data showing the shots are a crime against humanity.


"When this product [the COVID shots] came to market, I was very suspicious because I know a lot about health care," Dowd says. "I was on Wall Street and I used to analyze health care stocks. I knew that normal vaccines took seven to 10 years to prove effectiveness and safety.


This was an experimental vaccine, a nontraditional gene therapy that had never been tested on humans. I read the literature on the animal tests and they were an abomination. Then, this thing was approved in 28 days. They got rid of the control group. I knew it was Operation Warp Speed, so I was highly suspicious of this whole thing from the get-go.


Then in early 2021, I started hearing anecdotes that people were getting sick and/or injured, or died, from distant friends and relatives. I started reading about sudden athlete deaths, [and] suspected the vaccine right away. I didn't have the data that I have now, but I said to myself, 'You know, I'm going to look at insurance company results, funeral home results.'


That eventually led to excess mortality statistics … I'm known as 'the excess mortality guy' right now. What I've learned through my own personal experience is that Pharma is, on the whole, mostly fraudulent. Most drugs that have been approved by the FDA [U.S. Food and Drug Administration] aren't really all that safe and effective.


They have to recall so many drugs every year. The FDA has been wholly captured by the pharma industry. Seventy to 75% of the drug approval pharma arm of the FDA comes from pharma fees, directly from the companies, so this has been corrupted for a long time.


It's now exposed primarily because [the COVID shot] is [injuring and killing] such a large amount of people. It's hard to hide this one … This fraud is unveiled and out there for people to see, but it's only in the echo chamber. Mainstream media is still beholden to Big Pharma because of all the ad spend and the government policymakers … [who] want this to go away.


There's a giant cover-up going on as far as I'm concerned. The data that I'm going to talk about today is there for the global health authorities to see. They see what I see, and at this point it's negligence, malfeasance, a cover-up and a crime.


That's why I'm here, because I don't believe anybody has a right to tell me what to do with my body, and I can't believe this actually happened. The numbers I'm going to reveal to you are now a national security concern."

Group Life Insurance Statistics Tell a Curious Story

Dowd's concerns are based on a variety of statistics, including but not limited to government mortality and disability data, as well as data from private insurance companies, such as group life insurance data. As explained by Dowd, group life policies are policies given to large Fortune 500 corporations and mid-sized companies.

Basically, when you start to work at one of these companies, you sign onto a policy from Day 1 that includes a health care plan and life insurance plan (death benefit), which is typically one or two times your annual salary. The only way you can get a claim on these policies is if you die while employed. If you quit or get fired, you don't get this claim.

Group life insurance is a lucrative business for insurance companies because the death rates have historically been highly predictable. In the U.S., the available civilian labor force is about 164 million people in total. Of those, 98 million are actually employed, and of those 98 million, only small subset actually has group life insurance.


"These people are a tiny subset of the 98 million because these are the workers at the best corporations with access to the best health care. They're highly educated and employed, and you have to have some measure of health to be employed.


The industry did research in 2016 to determine how healthy this population is compared to the general U.S. population … This report said that in any given year, the group life policyholders die at one-third the rate of the general U.S. population. They experience a third the mortality rate of the general U.S. population, so they're healthy.


What happened in 2021 to this group? Well, let's talk about what happened in 2020. COVID affected everybody, and the general U.S. population experienced more excess mortality from COVID pre-vaccine than the group life holders, so that relationship helped. Well, in 2021 that flipped. Ages 25 through 64 of the group life policyholders, as reported by the Society of Actuaries, experienced 40% excess mortality.


The general U.S. population in 2021 experienced 32% excess mortality. This is year two of the pandemic with miracle vaccines. Isn't that interesting? A much healthier subset of the population died at a higher rate than the general population."
Disability Stats Reveal Jabs Are a National Security Concern

American disability statistics are equally revealing. Every month, the U.S. Bureau of Labor Statistics conducts surveys on disability. In the five years before COVID, the monthly disability rate was between 29 million and 30 million. Those are absolute numbers.

After the COVID jabs, starting in May 2021, the disability trend changed dramatically. As of September 2022, there were 33.2 million disabled Americans. That's an extra 3.2 million or 4.2 million, depending on whether you're using the 29 million or 30 million baseline. That's a three standard deviation rate of change since May 2021.

A three standard deviation means that the chance of this happening is 0.03%, so something happened around May 2021 that was highly unusual. Since then, the overall U.S. population has experienced an 11% rate of increase in disabilities, while the employed — which is about 98 million out of a total population of about 320 million — experienced 26% increased rate of disability.


"So, we have two different databases suggesting the same thing," Dowd says. "It was detrimental to your health to be employed in 2021 and 2022 … Something is happening to the most able-bodied amongst us, college students, those employed, those in the military, the frontline workers …


Those who are employed are getting disabled faster than the general U.S. population. That shouldn't happen. The employed amongst us are healthier, generally speaking … If you have a job, you tend to be able to show up at work. Basically, the bottom line is this. The only explanation for this that I can see is mandates for experimental biological inoculations …


One of my whistleblowers from the insurance [industry] told me that as of August 2022, the millennial cohort of the group life holders is still experiencing 36% excess mortality.


People in Fortune 500 companies are dying at a much more excessive rate than those who are not employed there, so this has implications for years to come. It's a national security concern as far as I can tell … We seem to have poisoned the most able-bodied amongst us through [COVID jab] mandates."

The same trends are seen in Europe. Excess mortality amongst the young has gone up. In the first year of the pandemic, old people died. In the second year, it suddenly shifted to younger working folks.
A Disaster in the Making

For now, the excess mortality trend in the U.S. has leveled out between 15% to 20% for the general population. In the U.K. and Europe, the excess mortality trend in the general population is between 10% and 20%. Meanwhile, American millennials in the workforce with group life policies have an excess death rate of 36% as of August 2022.

As noted by Dowd, if you're employed at a Fortune 500 company that mandate boosters, it makes sense that your excess mortality will be higher than the general population if the shots are harming people.

Many in the general population are too young to take the shots, are self-employed, work for small companies that aren't obliged to mandate shots, or are retired. In short, the general population has had greater choice when it comes to taking the shots or not. If these trends continue at this same rate, it's an absolute disaster for our economy and society at large.


"The CEO of OneAmerica, Scott Davison, said a 10% rise in excess mortality amongst younger-age working people is a three standard deviation event, or a once in a 200-year flood. That's just 10%. He said the 40% they saw in 2021 was just unfathomable. They couldn't even calculate what that meant.


We're above 10%, so we're well above the three standard deviation event. What we don't know is the long-term trends. Anecdotally, one young woman I know, [aged] 30, got it in December 2021.


She's presenting with heart issues now, in the month of October [2022]. She's got a heart rate beat per minute of 30, so she's got problems. I'm hearing about lots and lots of heart issues in my millennial friends' circles that have presented themselves well after the shot."

As detailed in "Is Long-COVID the Elephant in the Room?" recent research1 from Switzerland found the rate of subclinical myocarditis is hundreds of times more common than clinical myocarditis. In fact, 100% of those who got the jab suffered some level of heart injury, even if they were asymptomatic, as they all had elevated troponin levels (an indicator of or biomarker for heart damage).
Stock Trading as an Analogy for COVID Jab Uptake

The good news is that the uptake of the latest bivalent boosters is only 10%, which means 90% of those eligible for it have not gotten it. Hopefully, this is a sign of sanity returning. However, many remain stuck in the pro-mandate box for the simple reason that their egos are wrapped up in it.

Many didn't take and push the shots for personal health reasons. As noted by Dowd, "They did it for virtue signaling tribal reasons, and they wanted to feel superior to other people." To break the spell, they must come to the realization that they were duped, they were fooled, and that's painful.


"If you buy a stock and your investment thesis is proven wrong, what you should do is pull a 180 and sell the stock, because you're wrong. What I found, even with some of the greatest investors, is that if their ego was attached to it, they would ignore clear evidence that the thesis was compromised. Sometimes fraud would even be involved in some of these companies, but they would continue to buy the stock all the way down.


That's an analogy for what taking boosters is at this point — taking boosters for a product that doesn't work at all, doesn't prevent COVID nor transmission. Let's say you think it's safe and effective. But now there are serious safety concerns that are proven, so it's literally your ego that's going to kill you. We call that 'dumb money' on Wall Street, so think of this like a trade.


You either long [i.e., take a long position on] the vaccine or short the vaccine. Those of us who didn't take it are short. Those who are long have an opportunity to pull a 180 on this and not get boosters. That would be the equivalent of selling stock.


Those who continue to get boosters are getting longer as more and more evidence [against the COVID shots] rolls out. [Editor's note: In stock trading, a long position is held with the expectation that the stock will rise in value in the future. If the value goes down, you lose money.]


This is the greatest asymmetric information gap I've ever seen in my lifetime, and it's due to a whole host of factors — media blackouts, government corruption, regulator corruption and ego, people's individual ego. This is the greatest trade of my lifetime and, what side of the trade do you want to be on?


My hope is to convince people to cut their losses and stop taking this thing and then look at ways to heal the damage that's been done. The good news is there does seem to be people working on protocols to at least mitigate and hopefully reverse some of the damage."
Impacts on US Infrastructure

If excess mortality and disability rates remain catastrophically elevated, the impacts on our infrastructure will be severe. Dowd estimates 2 million to 3 million Americans have already been disabled by the shots. Officially, the unemployment rate is 3%, but if you add in the excess disabilities, you find that the real unemployment rate is actually around 6%.


"Why is that important? We have 3% unemployment yet we have help wanted signs everywhere. Well, the reason you have help wanted signs is because people who used to be able to work, able-boded Americans, are no longer able to work, so it's creating shortages.


There's also not complete disability. Some people are sucking it up and dragging their ass to work, but they're also missing days. A lot of people are calling in and missing days … I can also talk about what I'm seeing with supply chain with automobiles. My car was hit July 14th [2022]. My left headlight panel was destroyed and the radiator was damaged.


It took 10 days to get a police report because my police department has staff shortages. Then, I called around and there are shortages of parts all across the globe and the body shops are backed up. I couldn't even get a tow to a body shop until November, so I couldn't get an estimate to give to my insurance company. I had to do a photo estimate.


It took them about a month to get back to me, and then when I put in [a claim for] the repairs, my insurance company said, 'We're going to junk your car. It's a total loss. We'll cut you a check.' Now, the reason they did that was because they're making money off my junk car.


They're going to sell the parts, [which is why] they gave me more money than the Blue Book value … This is kind of the glacial beginning, what I call the 'glacial Mad Max' scenario.


Goods and services that we used to take for granted are going to start to disappear. Uber Eats, that's going to go the way of the dodo bird. There's just not going to be enough people to fill these jobs and it's going to become increasingly more difficult to get things. Supply chains are already broken. They're going to become more broken with less people on the margin.


Remember, supply chains are all done just-in-time. That was a big thing when I was on Wall Street. 'Just-in-time supply chain, super-efficient.' Well, just-in-time was algorithmically designed to use the least amount of people. Now, you just need a couple of people to call in sick or disappear, and everything gets backed up. So, this is beginning.


I think it's going to get worse and worse. What I'm hearing about the medium-term impacts scare me. Because of the uptake in boosters has lessened, we should have seen excess mortality start to drop into single digits. But it's not.


It's still running [high], and I suspect when the numbers are in from the flu season this winter, excess mortality will trend up again because people's immune systems are compromised. Illnesses that would have been easy to withstand are going to knock some people out."
Life Expectancy Has Plummeted

At the end of August 2022, we also discovered that life expectancy in the U.S. dropped precipitously during 2020 and 2021,2 which further supports the hypothesis that the shots are prematurely killing people.

As I was preparing for my interview with Ed, I realized I wanted to discuss the worst decrease in life expectancy in the U.S. in over 100 years with him, as he had not discussed it in his book. I used a few of the non-Google search engines and could not find it at all. Then I realized I saved a copy of the story in one of my PowerPoint lectures (see below):


If I had not saved this screenshot and not had the precise headline to search for I would likely have never found the article.

In 2019, the average life span of Americans of all ethnicities was nearly 79 years. By the end of 2021, life expectancy had dropped to 76 — a loss of nearly three years. Typically, a drop in life expectancy by a mere month or two is a big deal, so a three-year loss is a sign that something catastrophic has occurred.

It's also rather incriminating that The New York Times article3 that reported this historical decline in life expectancy was quickly deleted, as were all reposts. To me, the decrease in life expectancy is prima facie evidence that the COVID shots are a dangerous fraud. Probably, the article was scrubbed to protect the pro-jab narrative.

This is a classic illustration of what the global cabal is doing, and I discussed it in great depth with an upcoming interview with Whitney Webb. It is clear this censorship and removal of important information will only worsen with time. So if you value a video or article it would be really helpful to download it to your personal drives as it very well may be gone the next time you go to look for it.
More Information

To learn more, be sure to pick up a copy of Dowd's book, "Cause Unknown: The Epidemic of Sudden Deaths in 2021 and 2022." To stay abreast on Dowd's ongoing work, you can also follow him on GETTR.


"I'm not a scientist. I'm not a doctor. I'm a financial capital markets expert," Dowd notes. "What do we do in financial capital markets? We accumulate information edges over other people to make decisions on asset classes, to make money before everybody else sees the trend change. That's how you make money.


I live in the world between perception, reality and timing of that switch from perception to reality. Right now, the perception by 90% of the population seems to be that the COVID shot is a safe and effective and I'm crazy. Well, my data suggests that I'm not crazy. Not only am I not crazy, you're so wrong it's going to be detrimental to your health.


The book is a journey through how I think. I present the theory of the case. It's simple deductive reasoning. You don't have to believe me, but you have to ask this question: 'If 2020 was so exciting to the media and the health officials that counted all the deaths with such glee, why are they not talking about the excessive death rates we're now seeing globally, especially amongst the younger age working folks and the employed folks?'


There seems to be crickets on that, so you have to ask yourself, 'If that's not a national security concern and a national health crisis, then what is?' Why the silence? Well, prima facie evidence of a cover-up is my thesis … Look at my book as a stock thesis. It's my investment case on why I would pitch a stock to you … I'm just pitching you a trade.


Get out of the vaccine. Stop taking them. You're on the wrong side of the trade, and if you don't listen to me, instead of losing money, you're probably going to lose your health and/or life."
A Red Pill for Christmas

A great feature of "Cause Unknown: The Epidemic of Sudden Deaths in 2021 and 2022" is that it's not going to overwhelm you with complex statistical analysis. It's a simple read with lots of pictures and graphs. It also includes QR codes to references so you can rapidly confirm them.


"Everything I sourced," Dowd says. "It's a powerful book. It's a book that I hope changes the marginal mind … I think it makes a great Christmas gift for the family member who doesn't see the reality we see and, again, it's coming from a Wall Street guy, laid out as an investment thesis. You can disagree, but all the stuff that I put in the book is sourced and the data is the data …


What we don't do in the book is we don't get into the who and why. We don't want to assault someone's worldview, but the data's so compelling, we do say at the end of the book … 'There's a cover-up going on and malfeasance.'


Jessica Rose, Ph.D., said in an interview with me, and I put her quote in the book, 'Some things are worse than death.' The most acute adverse reaction is death. But there are other ones that can make your life pretty miserable for a long, long time, and also make other people's lives miserable that have to take care of you.


When you think about labor statistics, if there's someone in the house that's disabled severely, the person who's not disabled loses work hours and work weeks taking care of that person, taking them to hospital visits, what have you.


Also, think about the hospital infrastructure that's going to be overwhelmed, especially with the health care workers who were mandated to take all these jabs. We're going to have a health care crisis, whether you know it or not.


It's coming, and you're not going to have access to health care … That's why I think people need to look at holistic health themselves and get as healthy as possible right now … Do what you can outside the medical system because soon it's not going to be there for you."

Sunday, November 27, 2022

The Truth About Ivermectin

 Medical miracle or notorious lynchpin of misinformation?

0:0021:31

Ivermectin has been hailed as a “wonder drug” and, according to the UNESCO World Science Report, a critical component of “one of the most triumphant public health campaigns ever waged in the developing world.”

However, since the onset of the COVID-19 pandemic, the National Institutes of Health (NIH) and affiliated health authorities have vociferously recommended against ivermectin as a potential treatment for the virus.

Though the Food and Drug Administration (FDA) has approved ivermectin for human use in treating conditions caused by parasites, it has also insisted that ivermectin “has not been shown to be safe or effective” when it comes to treating COVID-19.

In a social media message that has gone viral, the FDA labeled it as a drug for horses and not fit for human consumption: “You are not a horse. You are not a cow. Seriously, y’all. Stop it.”

The post made headlines and was one of the FDA’s most successful social media campaigns. Yet, research findings seem to contradict the public health organization’s recommendations.

A growing body of research shows that ivermectin is an essential treatment for COVID-19. Many doctors have praised the drug for its broad yet effective antiparasitic, antiviral, antibacterial, anti-inflammatory, anti-cancer, and autophagic properties.

Ivermectin: Antiparasitic Beginnings

Ivermectin made its name through its significant benefits in treating parasitic infections.

In 1973, Satoshi Omura and William C. Campbell, working with the Kitasato Institute in Tokyo, found an unusual type of Streptomyces bacteria in Japanese soil near a golf course.

In laboratory studies, Omura and Campbell discovered that this Streptomyces bacteria could cure mice infected with the roundworm Heligmosomoides polygyrus. Campbell isolated the bacteria’s active compounds, naming them avermectins, and the bacteria was thus called S. avermitilis.

Despite decades of searching worldwide, researchers have yet to find another microorganism that can produce avermectin.

It was changing one of the bonds of avermectin through a chemical process that produced ivermectin, which was proven successful in treating onchocerciasis and lymphatic filariasis, both of which are debilitating diseases common in the developing world.

Epoch Times Photo
A portrait of William Campbell and an illustration describing his work displayed on a screen during a press conference of the 2015 Nobel Medicine Prize. William Campbell and Satoshi Omura won the Nobel Medicine Prize for their discoveries of treatments against parasites—Avermectin, which was modified to Ivermectin. (JONATHAN NACKSTRAND/AFP via Getty Images)

Though its broad antiparasitic functions are not well understood, it is known that ivermectin penetrates parasites’ nervous systems, turning off their neurons’ actions, possibly deactivating and killing them.

As part of a donation campaign launched in 1988 by Merck & Co., Inc., the manufacturer of ivermectin, the drug was used in Africa to treat river blindness. Also called onchocerciasis, river blindness is a tropical disease caused by Onchocerca volvulus worms. It is the second-most common cause worldwide of infectious blindness.

The Onchocerca worms mature in the skin of an infected individual (“the host”). After mating, female worms can release into the host’s skin up to 1,000 microfilariae a day; the female worms live for 10 to 14 years. The presence of these worms can lead to scarring in the tissues and, when microfilariae invade the eye, can cause visual impairment or complete loss of vision.

The World Health Organization estimates that 18 million people are infected globally, and 270,000 have been blinded by onchocerciasis.

When Merck distributed ivermectin in areas hardest hit by the disease, treatment benefited the residents’ overall health and led to economic recovery. Ivermectin replaced previous drugs that had devastating side effects.

“Ivermectin proved to be virtually purpose-built to combat Onchocerciasis,” Omura wrote in a study he co-authored in 2011.

Ivermectin has also proven effective against lymphatic filariasis, known as elephantiasis. Parasitic worms transmitted through the bite of an infected mosquito can grow and develop in lymphatic vessels, which regulate the body’s water balance. When certain vessels are blocked, the areas—typically the legs and genitals—can swell, with the legs enlarging to elephant-like stumps.

Worldwide, more than 120 million people are infected, 40 million of whom are seriously incapacitated and disfigured.

The World Health Organization listed ivermectin as an essential drug and has advised many countries to run annual campaigns to rid people of these parasites. Such recommendations are a solid testament to ivermectin’s safety.

For their work, including the discovery of avermectin, in 2015, Omura and Campbell were among three recipients of the Nobel Prize in Physiology or Medicine.

It is an indispensable drug for the underdeveloped world, with about 3.7 billion doses administered as part of global campaigns during the past 30 years. To this day, ivermectin remains a staple drug of tropical areas and an essential drug in treating onchocerciasis, lymphatic filariasis, strongyloidiasis, and scabies.

Ivermectin and COVID-19

Analyses of studies on ivermectin have found it effective as a prevention, a treatment for acute COVID-19, and in advanced stages of infection by the virus.

1. Ivermectin as a Prophylaxis

Prophylaxis intervenes in the first phases of COVID-19 infection, which is mainly asymptomatic, when the virus replicates to increase its viral load—symptom onset occurs after the viral load peaks.

Ivermectin can be effective in the early stages of infection. Outside the cells, ivermectin can attach to parts of the virus, immobilizing it and preventing it from entering and infecting human cells.

Ivermectin can also enter the cell to prevent the virus from replicating. SARS-CoV-2 needs cell replication machinery to make more of the virus; ivermectin attaches and blocks a protein critical to this process, preventing viral production.

Additionally, ivermectin can be absorbed from the skin and stored in fat cells for a long time.

“Because it’s lipid soluble, it is stored and slowly released, [so] once you’ve taken a prophylactic dose, and I think it’s like the cumulative dose of about 400mg, that your risk of getting COVID is close to zero and you can actually stop it for a while,” said Dr. Paul Marik, a widely published critical care specialist with 500 peer-reviewed papers to his name, in an interview with The Epoch Times.

Epoch Times Photo
Dr. Paul Marik in Kissimmee, Fla. on Oct. 14, 2022. (The Epoch Times)

Marik co-founded the Front Line COVID-19 Critical Care Alliance (FLCCC), a group of physicians formed in the early days of the pandemic and dedicated to treating COVID-19. According to interviews, many of the group’s doctors have successfully treated COVID-19 with ivermectin. The organization’s other co-founder, Dr. Pierre Kory, has written a book about ivermectin’s use and controversy during the pandemic.

Dr. Sabine Hazan, a gastroenterologist with 22 years of experience in clinical research, told The Epoch Times that she would advise ivermectin use for only a short time in critical patients rather than recommending the use of it as a prophylaxis.

Continuous use of ivermectin—as with all drugs—can make the body dependent on the drug rather than working to fix itself.

2. Ivermectin for Early and Acute COVID

Many peer-reviewed studies have found that ivermectin, when used by itself or in conjunction with other therapies in symptomatic patients, reduces ventilation time, time for recovery, and the risk of progressing to severe disease. (pdf 1, pdf 2, pdf 3)

This is likely due to ivermectin’s anti-inflammatory role in multiple pathways, achieved by clearing out the viral particles by immobilizing them, reducing inflammation, and improving mitochondrial action.

Suppose the early viral replication is not controlled and cleared out soon enough by the body’s immune system. In that case, the infection can become severe or even hyperinflammatory, possibly leading to systemic organ failures.

Ivermectin can also directly interact with immune pathways, suppressing inflammation and reducing the chances of developing a cytokine storm. A cytokine storm occurs when the immune system is hyperactive and hyperinflammatory. Though ivermectin can help to clear out the virus and its particles, the inflammatory state of the tissues and the organs can often cause more damage than the virus itself.

Ivermectin also likely improves gut health, which plays an essential role in immunity by preventing bacteria and viruses from infecting people via the gut.

In a published study, Hazan hypothesized that ivermectin helps COVID-19 patients by increasing the levels of Bifidobacteria—a beneficial bacteria—in the gut.

As the CEO and founder of her own genetic sequencing research laboratory, ProgenaBiome, Hazan noticed that the Bifidobacteria levels in her stools would increase after she took ivermectin. Critical COVID patients would have “zero Bifidobacteria,” which can often be a sign of poor health.  

In her peer-reviewed study on hypoxic patients, she observed that COVID patients with low oxygen levels from the cytokine storms in their lungs would improve within hours of administering ivermectin.

“When people die of COVID, they die from the cytokines—they couldn’t breathe anymore. It’s almost like an anaphylactic reaction. So when you give them ivermectin at the moment they’re about to crash, you’re boosting the Bifidobacteria [and increasing their oxygen],” Hazan said.

She explained that ivermectin is a fermented product of Streptomyces bacteria. Streptomyces are within the same group Bifidobacteria are from, which may explain why ivermectin temporarily boosts Bifidobacteria.

Ivermectin also helps with mitochondrial function. During severe COVID-19, patients often experience pulmonary dysfunctions due to lung inflammation, reducing oxygen flow. This can cause stress to the mitochondria, leading to fatigue, and, when severe, may cause cell and tissue death. Ivermectin has been shown to increase energy production, indicating that it is beneficial to the mitochondria.

Furthermore, ivermectin can bind to the spike protein—a distinctive structural feature of the COVID virus which has a crucial role in its pathogenesis. In systemic disease, the spike protein can enter the bloodstream and bind to red blood cells to form blood clots. Ivermectin can prevent blood clots from forming in the body.

3. Ivermectin for Long COVID and Post-Vaccine Symptoms

The number of studies supporting ivermectin to treat long COVID and post-COVID-19 vaccine symptoms is limited. However, doctors treating these conditions have observed successful results with ivermectin.

An Argentinian study published in March 2021 is the only peer-reviewed study evaluating ivermectin for long COVID.

Researchers found that in patients reporting long COVID symptoms—including coughing, brain fog, headaches, and fatigue—ivermectin alleviated their symptoms.

Mechanistically, ivermectin can improve autophagy. This process is usually switched off during COVID-19 infections. By switching autophagy back on, ivermectin can help cells clear remnant viral proteins out, returning stability to the cell.

Like acute and severe COVID-19, chronic spike protein triggers inflammation, and ivermectin can reduce such responses by suppressing inflammatory pathways and lessening the damage to tissues and blood vessels.

The Changing Public Health Messaging on Ivermectin

The NIH’s stance on ivermectin has changed several times.

Early in the pandemic, there was little information on ivermectin as a potential treatment for the virus.

The first study that mentioned ivermectin as a potential COVID-19 treatment came from Australia in April 2020. Researchers administered ivermectin to SARS-CoV-2-infected monkey kidney cells in the laboratory and found the drug beneficial in very high doses. However, the researchers concluded that further study was needed. Many health agencies, including the NIH, the CDC, and other global health regulators concluded that ivermectin could kill the virus only at toxic levels.

Even now, NIH’s statement on ivermectin for COVID-19 reads: “Ivermectin has been shown to inhibit replication of SARS-CoV-2 in cell cultures. However, pharmacokinetic and pharmacodynamic studies suggest that achieving the plasma concentrations necessary for the antiviral efficacy detected in vitro would require administration of doses up to 100-fold higher than those approved for use in humans.”

In October 2020, the first clinical study showing the benefits of ivermectin was published by the journal CHEST. The study found ivermectin to reduce mortality rates in COVID-19 patients and garnered immediate attention.

The study’s lead author, Dr. Jean-Jacques Rajter, is a critical care doctor specializing in pulmonary medicine.

Rajter gave a testimony (pdf) of his findings to the Senate Committee on Homeland Security & Governmental Affairs in December 2020.

The day after he saw the Australian study, one of his COVID patients dramatically deteriorated from breathing normally at room oxygen levels to requiring intubation. The patient’s son pleaded with Rajter to save his mother using whatever options available. Rajter recognized that  hydroxychloroquine would be ineffective in the advanced stages of COVID. After much deliberation, he tried ivermectin.

“The patient deteriorated as expected for about 12 more hours but stabilized by 24 hours and improved by 48 hours. After this, two more patients had similar issues and were treated with the ivermectin-based protocol. Based on experience, these patients should have done poorly, yet they all survived,” the testimony read.

More clinical studies were published, showing the benefits of ivermectin as a prophylactic treatment. (pdf 1, pdf 2).

The findings encouraged the use of ivermectin among doctors desperate to find a cure.

Meanwhile, by October 2020, research into COVID-19 vaccines and the use of remdesivir to treat the virus was already in full swing.

According to the FDA, specific criteria should be met for the EUA (Emergency Use Authorization) to be granted for vaccines and medications, including that there are “no adequate, approved, and available alternatives.”

Some doctors say that if ivermectin’s use for COVID had been approved, it would have made the EUAs for vaccines and remdesivir null and void.

Following the Australian study, the FDA published a statement, “FAQ: COVID-19 and Ivermectin Intended for Animals,” highlighting the use of ivermectin in animals and advising against the use of ivermectin for COVID-19.

The NIH also discouraged the use of ivermectin, albeit briefly. On Jan. 14, 2021, the NIH changed its statement, writing that there was no evidence to recommend or disapprove the use of ivermectin. However, in April 2022, the statement changed to strongly disapproving of using ivermectin.

“We [Marik, Kory, and Dr. Andrew Hill, a virologist and consultant to the WHO] had a conference with NIH in January of 2021. We presented our data, and Andrew Hill presented the data he had done…there were a number of studies at that point, which were very positive,” said Marik.

Health Authority Overreach

Despite the NIH’s neutral statement on ivermectin for most of 2021, the FDA actively campaigned against using ivermectin in COVID-19 patients. On Aug. 26,  2021, the CDC sent an emergency warning against using ivermectin; a few weeks later, the American Medical Association and affiliated associations called for an end to ivermectin use.

Many doctors were thus discouraged from using ivermectin, and pharmacies refused to prescribe it. State health agencies warned against using ivermectin, and medical boards removed the medical licenses of doctors who prescribed ivermectin, alleging misinformation.

Yet using the FDA’s statement against ivermectin to ban its use in COVID-19 cases would be considered an overreach. Since the FDA approved ivermectin in 1996, this made the drug acceptable for off-label use.

“The fact that it’s not FDA approved for COVID is irrelevant because the FDA endorses the use of off-label drugs at the clinician’s discretion,” said Marik.

As an ironic side effect of the messaging on ivermectin, people suddenly found themselves unable to access ivermectin, and some turned to veterinary-grade ivermectin.

Though veterinary ivermectin is the same product as medicinal ivermectin, the manufacturing standard is not the same as it is for human-grade pharmaceuticals.

Contradictory Research and Campaigns

Though the initial research in 2020 showed promising results for ivermectin, published studies reported conflicting findings by the following year.

The NIH has funded many studies on the effectiveness of ivermectin, the most recent being ACTIV-6.

Individuals can participate in the study once they develop COVID by selecting ivermectin from four other drugs. The drug was sent to them via mail. This method means that some people in the study could have recovered by the time they received the ivermectin.

There are some controversies regarding this study.

The first is that the authors changed the primary endpoints during the study, which is heavily frowned upon as it can affect the validity and reliability of the outcome.

Initially, the primary endpoint was the number of deaths, hospitalizations, and symptoms reported at day 14.

This was changed to the number of deaths, hospitalizations, and symptoms by day 28. In the actual published study, there was another change, with the endpoint being duration of COVID-19 symptoms.

A rapid review published by the Massachusetts Institute of Technology (MIT) implied that the endpoints were changed because, by the time the study commenced, there were far fewer events of death and hospitalizations; as a result, there would not be enough data for a reliable comparison.

Indeed, the data at the ACTIV-6 livestream showed that the ivermectin group reported only one death; this death would not be considered relevant to the research because the patient was hospitalized and died before he took ivermectin.

There were also further implementations in the study that could impact the observed effectiveness of the drug.

On average, this study’s participants received treatment six days after first reporting symptoms. Patients needed to report eligible symptoms and test positive for COVID-19 before receiving drugs. Due to this added time, about seven percent of the participants had no symptoms by the time ivermectin arrived.

Despite these negative findings for ivermectin, there is still some evidence that may demonstrate that ivermectin can be useful in treating COVID-19.

In the abstract, the authors concluded that taking ivermectin had “a posterior probability of benefit of .91,” this is another way of writing that ivermectin had a 91 percent probability of being more beneficial than placebo.

The percent of probability is below 95 percent, making the benefit of ivermectin insignificant.

 

Epoch Times Photo
Slides from the ACTIV-6 presentation on a statistically significant secondary endpoint findings.

Another secondary endpoint showed that by day 14, ivermectin already had a statistically significant 27 percent benefit with 98 percent probability of efficacy.

The FDA and NIH did not respond for comments by press time.

Marina Zhang is based in New York and covers health and science. Contact her at marina.zhang@epochtimes.com.

Copyright © Fight for Your Faith